A prognostic model for clinical response to bevacizumab in recurrent glioblastoma multiforme

被引：0
|
作者：
Urup, Thomas [1 ]
Michaelsen, Signe Regner [1 ]
Holst, Camilla Bjornbak [1 ]
Toft, Anders [1 ]
Christensen, Ib Jarle [2 ,3 ]
Grunnet, Kirsten [1 ]
Kosteljanetz, Michael [4 ]
Broholm, Helle [5 ]
Lassen, Ulrik [6 ]
Poulsen, Hans Skovgaard [1 ]
机构：
[1] Rigshosp, Finsen Ctr, Dept Clin Oncol, Dept Radiat Biol, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Rigshosp, Finsen Ctr, Finsen Lab, DK-2100 Copenhagen, Denmark
[3] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark
[4] Rigshosp, Neuroctr, Dept Neurosurg, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Dept Pathol, Ctr Diagnost Invest, DK-2100 Copenhagen, Denmark
[6] Rigshosp, Dept Clin Oncol, Finsen Ctr, Dept Radiat Biol,Phase Unit 1, DK-2100 Copenhagen, Denmark
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4306
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4306
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Bevacizumab in recurrent glioblastoma multiforme
    Tayah, Tania
    Ashrafieh
    Chahine, Georges Y.
    Kamar, Francois G.
    [J]. NEUROLOGY, 2008, 70 (11) : A296 - A297
  • [2] Irinotecan and bevacizumab in recurrent glioblastoma multiforme
    Jakobsen, Jan Nyrop
    Hasselbalch, Benedikte
    Stockhausen, Marie-Therese
    Lassen, Ulrik
    Poulsen, Hans Skovgaard
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (05) : 825 - 833
  • [3] Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Marcello, Jennifer
    Reardon, David A.
    Quinn, Jennifer A.
    Rich, Jeremy N.
    Sathornsumetee, Sith
    Gururangan, Sridharan
    Sampson, John
    Wagner, Melissa
    Bailey, Leighann
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4722 - 4729
  • [4] Stereotactic Radiosurgery and Bevacizumab for Recurrent Glioblastoma Multiforme
    Cabrera, Alvin R.
    Cuneo, Kyle C.
    Vredenburgh, James J.
    Sampson, John H.
    Kirkpatrick, John P.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (06): : 695 - 699
  • [5] Bevacizumab: A treatment option for recurrent glioblastoma multiforme
    Buie, Larry W.
    Valgus, John M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2008, 42 (10) : 1486 - 1490
  • [6] Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
    Pope, Whitney B.
    Kim, Hyun J.
    Huo, Jing
    Alger, Jeffry
    Brown, Matthew S.
    Gjertson, David
    Sai, Victor
    Young, Jonathan R.
    Tekchandani, Leena
    Cloughesy, Timothy
    Mischel, Paul S.
    Lai, Albert
    Nghiemphu, Phioanh
    Rahmanuddin, Syed
    Goldin, Jonathan
    [J]. RADIOLOGY, 2009, 252 (01) : 182 - 189
  • [7] Bevacizumab for Recurrent Glioblastoma Multiforme: A Meta-Analysis
    Wong, Eric T.
    Gautam, Shiva
    Malchow, Christopher
    Lun, Melody
    Pan, Edward
    Brem, Steven
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (04): : 403 - 407
  • [8] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    Schiff, David
    Purow, Benjamin
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (04): : 186 - 187
  • [9] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    David Schiff
    Benjamin Purow
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 186 - 187
  • [10] Bevacizumab for Recurrent Glioblastoma Multiforme: A Meta-Analysis
    Wong, Eric T.
    Gautam, Shiva
    Malchow, Christopher
    Lun, Melody
    Pan, Edward
    Brem, Steven
    [J]. ANNALS OF NEUROLOGY, 2010, 68 (04) : S61 - S62
12345